文献

J-GLOBAL ID：201802268079672115   整理番号：18A1012410

翻訳開始因子eIF2のサブユニットeIF2βは非小細胞肺癌のための有望な治療標的である

eIF2β, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer

著者 (20件)： Tanaka Ichidai (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Sato Mitsuo (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Kato Toshio (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Goto Daiki (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Kakumu Tomohiko (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Miyazawa Ayako (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Yogo Naoyuki (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Hase Tetsunari (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Morise Masahiro (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Sekido Yoshitaka (Department of Cancer Genetics, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Sekido Yoshitaka (Division of Cancer Biology, Aichi Cancer Center Research Institute, Nagoya, Japan) ,  Girard Luc (Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA) ,  Minna John D. (Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA) ,  Byers Lauren A. (Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA) ,  Byers Lauren A. (The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA) ,  Heymach John V. (Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA) ,  Heymach John V. (The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA) ,  Coombes Kevin R. (Department of Biomedical Informatics, Ohio State University, Columbus, OH, USA) ,  Kondo Masashi (Department of Respiratory Medicine, Fujita Health University, Toyoake, Japan) ,  Hasegawa Yoshinori (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan)
資料名： Cancer Science (Web)  (Cancer Science (Web))
巻： 109  号： 6  ページ： 1843-1852  発行年： 2018年 
JST資料番号： U0505A  ISSN： 1349-7006  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 非小細胞肺癌(NSCLC)の新規治療標的を同定するために,次...

シソーラス用語： ヒト ,...
準シソーラス用語： 腫瘍増殖

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1012410&from=J-GLOBAL&jstjournalNo=U0505A") }}

著者キーワード (5件)： 腺癌 ,  真核生物開始因子-2 ,  G1相細胞周期チェックポイント ,  ヘテロ三量体GTP結合蛋白質 ,  RNA干渉

分類 (2件)： 腫ようの化学・生化学・病理学  (GE02030N) ,  遺伝子発現  (EC02040Q)

タイトルに関連する用語 (5件)： 翻訳開始因子 ,  eIF2 ,  サブユニット ,  非小細胞肺癌 ,  治療標的